Picture of Jubilant Pharmova logo

JUBLPHARMA — Jubilant Pharmova News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

India's Jubilant Life Sciences eyes worst day in 5 months as Q1 profit slumps

** Shares of pharma and life sciences co  JULS.NS  fall as
much as 7% to 771.90 rupees, their biggest percentage loss since
March 30
    ** Company on Friday reported a 52% drop in June qtr profit
hurt by performance at its pharma division due to the COVID-19
pandemic  urn:newsml:reuters.com:*:nFWN2G00YY
    ** Pharma division's key contributors - radiopharma and 
allergy - are  currently  witnessing  lower volumes in U.S. due
to pandemic, brokerage Prabhudas Lilladher says in a note
    ** With travel restriction still in place for U.S. Food and
Drug Administration's visit to overseas plants, brokerage does
not expect new approvals for its key plants, which will impact
pharma segment
    ** About 740,600 shares change hands vs 30-day avg volume of
784,605 shares
    ** Shares are up 54.5% this year, as of last close

 (Reporting by Nallur Sethuraman in Bengaluru)
 ((Sethuraman.NR@thomsonreuters.com; (+91 8061822737); Reuters
Messaging: nallur.sethuraman.thomsonreuters.com@reuters.net))

Recent news on Jubilant Pharmova

See all news